Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT

Autor: Aline M. van der Loo–van der Schaaf, Elisabeth G.E. de Vries, Adrienne H. Brouwers, Annemiek M E Walenkamp, Ronald Boellaard, Johannes H. van Snick, Lotte D de Hosson

Publikováno v: de Hosson, L D, van der Loo-van der Schaaf, A M, Boellaard, R, van Snick, J H, de Vries, E G E, Brouwers, A H & Walenkamp, A M E 2019, ' Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT ', Clinical Nuclear Medicine, vol. 44, no. 8, pp. 612-619 . https://doi.org/10.1097/RLU.0000000000002640
Clinical Nuclear Medicine, 44(8), 612-619. LIPPINCOTT WILLIAMS & WILKINS
Clinical Nuclear Medicine, 44(8), 612-619. Lippincott Williams and Wilkins

Purpose Neuroendocrine tumors (NETs) can produce neuroendocrine amines resulting in symptoms. Selecting the most active amine-producing tumor lesions for local treatment might be beneficial for patients with metastatic small intestinal NET. Tumor bur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::796d685ef35abe6252e3e9def1ca6936
https://hdl.handle.net/11370/9e0a7de9-dafc-40f9-b850-3fa71ce86500